BMY
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
At close
$58.78
−$0.19 (−0.31%) Close
Pre-market $58.94 +$0.16 (+0.28%) 11:31 PM ET
Prev close $58.96
Open $58.88
Day high $58.88
Day low $58.78
Volume 1,254
Avg vol 12,278,936
Mkt cap
$118.20B
P/E ratio
17.04
FY Revenue
$48.19B
EPS
3.45
Gross Margin
71.08%
Sector
Healthcare
AI report sections
BMY
Bristol-Myers Squibb Company
Bristol-Myers Squibb is trading near the top of its 52-week range with firm upward price momentum over the past 3–6 months and multiple bullish technical signals, while momentum indicators approach overbought territory. Fundamentally, the company combines high margins, rising earnings, and strong free cash flow generation with elevated leverage and a recent decline in operating cash flow growth. Valuation appears moderate relative to cash generation, supported by a near-4% dividend yield and double-digit free cash flow yield, while short interest remains low despite a high short-volume share of daily trading.
AI summarized at 4:07 PM ET, 2026-03-02
AI summary scores
INTRADAY: 68 SWING: 77 LONG: 74
Volume vs average
Intraday (cumulative)
+14% (Above avg)
Vol/Avg: 1.14×
RSI
44.12 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.00 (Strong)
MACD: 0.02 Signal: 0.02
Short-Term
-0.16 (Weak)
MACD: -0.29 Signal: -0.13
Long-Term
-0.22 (Weak)
MACD: 0.22 Signal: 0.43
Intraday trend score 68.09

Latest news

BMY No articles found.
News is temporarily unavailable.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal